• Policy
• Orphan drug 'Voxzogo' wins nod
• by Lee, Hye-Kyung Jan 2, 2025 06:11am

• Policy
• Changes made to the drug approval system in the new year
• by Lee, Hye-Kyung Jan 2, 2025 06:11am

• Company
• Yuhan’s anticancer drug Leclaza secures European approval
• by Cha, Jihyun Jan 2, 2025 06:10am

• Policy
• ICER threshold for anticancer drugs set same as in 2024
• by Lee, Tak-Sun Jan 2, 2025 06:10am

• Company
• K-Bio to showcase CDMO·new drugs at the JP Morgan
• by Son, Hyung Min Jan 2, 2025 06:10am

• Opinion
• [Reporter’s View] The dilemma of companion diagnostics
• by Whang, byung-woo Dec 31, 2024 05:56am

• Policy
• Once-weekly insulin 'Awiqli' wins nod in KOR
• by Lee, Hye-Kyung Dec 31, 2024 05:56am

• Policy
• Approval of the 48hr Nurtec ODT for migraine imminent in KOR
• by Lee, Hye-Kyung Dec 31, 2024 05:55am

• Policy
• 29 new drugs with 45 ingredients reimb this year
• by Lee, Tak-Sun Dec 31, 2024 05:55am

• Policy
• Yungjin Pharm wins the 1st trial against Ofev
• by Kim, Jin-Gu Dec 31, 2024 05:44am